Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Prevalence of cortical gray matter atrophy may be overestimated in healthy aging brain

The belief that healthy older brains are substantially smaller than younger brains may stem from studies that did not screen out people whose undetected, slowly developing brain disease was killing off cells in key areas, according to new research. As a result, previous findings may have overestimated atrophy and underestimated normal size for the older brain.

8 Sep 2009

The Jordanian Stem Cell Company signs purchase agreement with Stemedica International

Stemedica Cell Technologies, Inc., ("Stemedica"), a world leader in stem cell research and manufacturing, announced the signing of an agreement today for its breakthrough stem cell and related technology. The Jordanian Stem Cell Company has signed a five year multi-million dollar agreement to purchase the technology from Stemedica's wholly-owned subsidiary, Stemedica International, S.A.

7 Sep 2009

Harmless shard from childhood virus shell may halt biological process

A harmless shard from the shell of a common childhood virus may halt a biological process that kills a significant percentage of battlefield casualties, heart attack victims and oxygen-deprived newborns, according to research presented Sunday, September 6, 2009, at the 12th European meeting on complement in human disease in Budapest, Hungary.

7 Sep 2009

CIHR funds for Alzheimer's and stroke research

The Canadian Institutes of Health Research (CIHR) has announced a grant totaling more than a million dollars for John F. MacDonald's research on Alzheimer's disease.

7 Sep 2009

Proposed Medicare cuts worry seniors and nursing homes

As Congress prepares to reconvene next week following an August recess replete with wide-ranging local discussion of how to fund health care reform, new polling finds both seniors and the public at large are strongly opposed to slashing Medicare-funded nursing home care to pay for the plan. Meanwhile, at events in Florida and Pennsylvania - states with large concentrations of Medicare beneficiaries - seniors and caregivers are urging their respective state congressional delegations to help preserve, protect and defend quality nursing home care as the legislative debate resumes Tuesday on Capitol Hill.

5 Sep 2009

Insomnia increases blood pressure

Can't sleep at night? A new study published in the journal Sleep has found that people who suffer from insomnia have heightened nighttime blood pressure, which can lead to cardiac problems. The investigation, which measured the 24-hour blood pressure of insomniacs compared to sound sleepers, was conducted by researchers from the Universit- de Montr-al, its affiliated H-pital du Sacr--C-ur de Montr-al Sleep Disorders Centre and the Universit- Laval.

5 Sep 2009

The 2009 Heart and Stroke Foundation Report on health of Ontario's kids

In 1998, the Heart and Stroke Foundation's Report Card on Canada's Kids took a hard look at the heart health of Canadian children aged 6-12. More than 10 years later, the Foundation shines the spotlight on Ontario's kids - and will be issuing its own Report Card on the heart health of this young cohort.

4 Sep 2009

Covidien's Sleep Diagnostic business acquired by Embla

Embla and Covidien have entered into a definitive agreement under which Embla will acquire Covidien's Sleep Diagnostic business. This includes the sleep diagnostic products sold under the Sandman(TM) brand name. Financial terms of the transaction were not disclosed. Completion of the sale is subject to customary closing conditions.

4 Sep 2009

Brain screening tests may do more harm than good

Researchers warn that paid-for brain scans - increasingly popular with healthy people who want to allay fears about undiagnosed brain cancer and stroke - may do more harm than good.

4 Sep 2009

Reliable and relevant information needed to rein in the costs of federal health-care programs, says study

For economists and policy-makers to understand the true value of the costs and savings of preventive health programs for chronic disease, the Congressional Budget Office (CBO) should incorporate long-term clinical outcomes data and look beyond the 10-year window when making cost estimates, says a team of University of Chicago researchers in today's issue of Health Affairs.

3 Sep 2009

Boston Scientific reports two-year data from SYNTAX clinical trial

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific (NYSE: BSX), has reported two-year data from its SYNTAX clinical trial comparing percutaneous coronary intervention (PCI) using the Taxus(R) Express(R) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery.

3 Sep 2009

UK Performance Network signs agreements with South West and thirteen PCTs

The UK Performance Network announced it has signed agreements with the South West Strategic Health Authority and thirteen primary care trusts (PCTs) in the South West as new subscribers.

3 Sep 2009

Medtronic's COPE-HCV clinical study commences

Medtronic, Inc., today reported the initiation and first enrollments of patients in COPE-HCV (COntinuous Interferon Delivery via the Medtronic Paradigm Pump Infusion System Clinical Evaluation for Chronic HCV), the company’s first-ever clinical study using an external pump infusion system to treat patients with the hepatitis C virus (HCV).

3 Sep 2009

Low HDL-cholesterol and high triglycerides linked to increased risk of CHD

Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.

3 Sep 2009

SYNTAX clinical trial results announced

Boston Scientific Corporation (NYSE: BSX) today announced two-year data from its SYNTAX clinical trial comparing percutaneous coronary intervention (PCI) using the TAXUS((R)) Express((R)) Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft (CABG) surgery.

3 Sep 2009

SRC raises funds through concert to help autistic children

The Sensory Research Center (SRC) held its first benefit, dessert and silent auction concert featuring LA Collaboration on the last week of August 2009. SRC Founder, Jennifer Hoffiz, said, "The concert was well attended and the talent of the performers was absolutely amazing. The concert and the silent auction allow SRC to offer 3 or 4 scholarships for children, whose parents/grandparents simply can not afford the neurosensory program, to receive this much needed therapy." One grandparent, Juanita Torres, who takes care of her twin autistic grandchildren, shared what it would mean to their family to receive a scholarship.

3 Sep 2009

Study reveals that obstacle avoidance depends on ancient visual pathways in the brain

Except in clumsy moments, we rarely knock over the box of cereal or glass of orange juice as we reach for our morning cup of coffee. New research at The University of Western Ontario has helped unlock the mystery of how our brain allows us to avoid these undesired objects.

3 Sep 2009

Strelitz Diabetes Center awarded a two-year grant for 12-LO research

Scientists at Eastern Virginia Medical School's Strelitz Diabetes Center have been awarded a two-year grant totaling $472,683 by the Juvenile Diabetes Research Foundation (JDRF).

3 Sep 2009

m.pulse system for MCP therapy installed in ten hospitals

Cardiola AG announced today that it has placed its patented m.pulse system in 10 hospitals located in Germany and Switzerland, on the heels of the system’s CE-Mark approval. MCP was previously only available in a clinical setting. Now, m.pulse is the world’s first and only device enabling CAD patients to receive MCP therapy at home.

3 Sep 2009

CIF launches campaign by distributing a "Ten Tips "card to help parents easily identify potential life threatening injuries

As high school student-athletes begin the academic year and participate in double-day sports practices statewide, the California Interscholastic Federation is drawing attention to the health risks associated with concussions, heat stroke and dehydration.

3 Sep 2009